National Multicentre Study on Lipid Profile in Noonan Syndrome and Related Disorders: Trends by Age, Gender and Genotype

ConditionsRASopathies Noonan Syndrome

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age2-35

SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna

About this trial

RASopathies, including Noonan syndrome, involve dysmorphisms, metabolic alterations, and an unfavorable lipid profile. This study investigates lipid and glucose metabolism to improve patient care.

Eligibility criteria

Qualifiers

Clinically diagnosed RASopathy confirmed by molecular testing;

Patients referred to participating centers between 01/01/2001 and 31/12/2022;

Age at enrollment between 2 and 35 years, inclusive;

Obtaining informed consent.

Disqualifiers

None.

Trial design

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Locations14

Select a site below to view it on the map.

Sponsors and collaborators

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Lead sponsor

Source ClinicalTrials.gov